Literature DB >> 24075898

High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association.

Christopher M Wrobel1, Timothy R Geiger, Rebecca N Nix, Aaron M Robitaille, Sandra Weigand, Alfredo Cervantes, Miguel Gonzalez, Jennifer M Martin.   

Abstract

LMP-1 is a constitutively active Tumor Necrosis Factor Receptor analog encoded by Epstein-Barr virus. LMP-1 activation correlates with oligomerization and raft localization, but direct evidence of LMP-1 oligomers is limited. We report that LMP-1 forms multiple high molecular weight native LMP-1 complexes when analyzed by BN-PAGE, the largest of which are enriched in detergent resistant membranes. The largest of these high molecular weight complexes are not formed by purified LMP-1 or by loss of function LMP-1 mutants. Consistent with these results we find a dimeric form of LMP-1 that can be stabilized by disulfide crosslinking. We identify cysteine 238 in the C-terminus of LMP-1 as the crosslinked cysteine. Disulfide crosslinking occurs post-lysis but the dimer can be crosslinked in intact cells with membrane permeable crosslinkers. LMP-1/C238A retains wild type LMP-1 NF-κB activity. LMP-1's TRAF binding, raft association and oligomerization are associated with the dimeric form of LMP-1. Our results suggest the possibility that the observed dimeric species results from inter-oligomeric crosslinking of LMP-1 molecules in adjacent core LMP-1 oligomers.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BMH; BN-PAGE; Complex formation; EBV; EGS; Epstein–Barr virus; IFNα; LMP-1; Latent Membrane Protein-1; Lipid raft; N-ethylmaleimide; NEM; Oligomerization; TMEA; TRAF; Tumor Necrosis Receptor Associated Factor; bismaleimidohexane; blue native polyacrylamide gel electrophoresis; ethylene glycol bis[succinimidylsuccinate; interferon alpha; tris-[2-maleimidoethyl]amine

Mesh:

Substances:

Year:  2013        PMID: 24075898      PMCID: PMC3925771          DOI: 10.1016/j.virusres.2013.09.025

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  76 in total

1.  A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.

Authors:  E Hatzivassiliou; W E Miller; N Raab-Traub; E Kieff; G Mosialos
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

2.  Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs.

Authors:  S R Brodeur; G Cheng; D Baltimore; D A Thorley-Lawson
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

3.  Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.

Authors:  M Sandberg; W Hammerschmidt; B Sugden
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.

Authors:  T Mitchell; B Sugden
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation.

Authors:  J E Floettmann; M Rowe
Journal:  Oncogene       Date:  1997-10-09       Impact factor: 9.867

6.  Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

Authors:  O Gires; U Zimber-Strobl; R Gonnella; M Ueffing; G Marschall; R Zeidler; D Pich; W Hammerschmidt
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

7.  Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.

Authors:  E Kilger; A Kieser; M Baumann; W Hammerschmidt
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

8.  High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells.

Authors:  B Clausse; K Fizazi; V Walczak; C Tetaud; J Wiels; T Tursz; P Busson
Journal:  Virology       Date:  1997-02-17       Impact factor: 3.616

9.  Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Authors:  O Devergne; E Hatzivassiliou; K M Izumi; K M Kaye; M F Kleijnen; E Kieff; G Mosialos
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

Review 10.  Structural characteristics of CD40 ligand that determine biological function.

Authors:  W C Fanslow; S Srinivasan; R Paxton; M G Gibson; M K Spriggs; R J Armitage
Journal:  Semin Immunol       Date:  1994-10       Impact factor: 11.130

View more
  1 in total

1.  The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.

Authors:  Mujeeb R Cheerathodi; David G Meckes
Journal:  Future Virol       Date:  2018-12-03       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.